4//SEC Filing
Deflin Gayle 4
Accession 0001104659-23-061819
CIK 0001297184other
Filed
May 16, 8:00 PM ET
Accepted
May 17, 4:05 PM ET
Size
4.9 KB
Accession
0001104659-23-061819
Insider Transaction Report
Form 4
Deflin Gayle
Director
Transactions
- Sale
Common Stock
2023-05-15$43.15/sh−1,500$64,728→ 8,682 total
Footnotes (1)
- [F1]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $43.149 to $43.17, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.
Documents
Issuer
Amphastar Pharmaceuticals, Inc.
CIK 0001297184
Entity typeother
Related Parties
1- filerCIK 0001866024
Filing Metadata
- Form type
- 4
- Filed
- May 16, 8:00 PM ET
- Accepted
- May 17, 4:05 PM ET
- Size
- 4.9 KB